Bausch Health Companies Stock Performance
| BHC Stock | CAD 11.95 0.10 0.84% |
On a scale of 0 to 100, Bausch Health holds a performance score of 15. The firm shows a Beta (market volatility) of -0.76, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Bausch Health are expected to decrease at a much lower rate. During the bear market, Bausch Health is likely to outperform the market. Please check Bausch Health's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Bausch Health's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Bausch Health displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 2:1 | Ex Dividend Date 2010-11-10 | Last Split Date 2000-10-05 |
1 | Sale Rumors Lift Both Bausch Lomb And Parent Bausch Health - A Breakthrough Is Likely - Seeking Alpha | 09/19/2024 |
2 | Bank of Montreal Can Decreases Stock Position in Bausch Health Companies Inc. - MarketBeat | 10/01/2024 |
3 | Zacks Research Has Bullish Outlook for BHC FY2024 Earnings - MarketBeat | 11/22/2024 |
| Begin Period Cash Flow | 591 M |
Bausch |
Bausch Health Relative Risk vs. Return Landscape
If you would invest 823.00 in Bausch Health Companies on September 1, 2024 and sell it today you would earn a total of 372.00 from holding Bausch Health Companies or generate 45.2% return on investment over 90 days. Bausch Health Companies is generating 0.6424% of daily returns assuming 3.2173% volatility of returns over the 90 days investment horizon. Simply put, 28% of all stocks have less volatile historical return distribution than Bausch Health, and 88% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bausch Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bausch Health Companies, and traders can use it to determine the average amount a Bausch Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1997
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BHC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.22 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.64 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Bausch Health is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bausch Health by adding it to a well-diversified portfolio.
Bausch Health Fundamentals Growth
Bausch Stock prices reflect investors' perceptions of the future prospects and financial health of Bausch Health, and Bausch Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bausch Stock performance.
| Return On Equity | -23.05 | ||||
| Return On Asset | 0.0415 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 33.52 B | ||||
| Shares Outstanding | 367.8 M | ||||
| Price To Book | 18.74 X | ||||
| Price To Sales | 0.46 X | ||||
| Revenue | 8.76 B | ||||
| Gross Profit | 5.76 B | ||||
| EBITDA | 2.2 B | ||||
| Net Income | (611 M) | ||||
| Cash And Equivalents | 564 M | ||||
| Cash Per Share | 2.49 X | ||||
| Total Debt | 22.39 B | ||||
| Debt To Equity | 906.20 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | (3.19) X | ||||
| Cash Flow From Operations | 1.03 B | ||||
| Earnings Per Share | (0.67) X | ||||
| Market Capitalization | 4.4 B | ||||
| Total Asset | 27.35 B | ||||
| Retained Earnings | (9.78 B) | ||||
| Working Capital | 1.29 B | ||||
About Bausch Health Performance
By examining Bausch Health's fundamental ratios, stakeholders can obtain critical insights into Bausch Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Bausch Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 220.23 | 128.82 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | 0.58 | 0.61 |
Things to note about Bausch Health Companies performance evaluation
Checking the ongoing alerts about Bausch Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bausch Health Companies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bausch Health appears to be risky and price may revert if volatility continues | |
| Bausch Health has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 8.76 B. Net Loss for the year was (611 M) with profit before overhead, payroll, taxes, and interest of 5.76 B. | |
| About 71.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Zacks Research Has Bullish Outlook for BHC FY2024 Earnings - MarketBeat |
- Analyzing Bausch Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bausch Health's stock is overvalued or undervalued compared to its peers.
- Examining Bausch Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bausch Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bausch Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bausch Health's stock. These opinions can provide insight into Bausch Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.